• ISSN 1674-8301
  • CN 32-1810/R
Volume 30 Issue 5
Turn off MathJax
Article Contents

Jianming Wu, Ling Li. Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications[J]. The Journal of Biomedical Research, 2016, 30(5): 361-372. doi: 10.7555/JBR.30.20150131
Citation: Jianming Wu, Ling Li. Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications[J]. The Journal of Biomedical Research, 2016, 30(5): 361-372. doi: 10.7555/JBR.30.20150131

Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications

doi: 10.7555/JBR.30.20150131
Funds:

This work was supported in part by grants from the National Institute of Health (HL117652) (to JW) and the Academic Health Center (Faculty Research Development Program) of the University of Minnesota(to LL and JW).

  • Received: 15 September 2015
  • Issue Date: September 2016
  • Alzheimer's disease (AD) is a prevalent and debilitating neurodegenerative disorder in the elderly. The etiology of AD has not been fully defined and currently there is no cure for this devastating disease. Compelling evidence sug-gests that the immune system plays a critical role in the pathophysiology of AD. Autoantibodies against a variety- of molecules have been associated with AD. The roles of these autoantibodies in AD, however, are not well -understood.This review attempts to summarize recent findings on these autoantibodies and explore their potential as diagnostic/ prognostic biomarkers for AD, their roles in the pathogenesis of AD, and their implications in the development of effective immunotherapies for AD.
  • 加载中
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2904) PDF downloads(588) Cited by()

Related
Proportional views

Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications

doi: 10.7555/JBR.30.20150131
Funds:

This work was supported in part by grants from the National Institute of Health (HL117652) (to JW) and the Academic Health Center (Faculty Research Development Program) of the University of Minnesota(to LL and JW).

Abstract: Alzheimer's disease (AD) is a prevalent and debilitating neurodegenerative disorder in the elderly. The etiology of AD has not been fully defined and currently there is no cure for this devastating disease. Compelling evidence sug-gests that the immune system plays a critical role in the pathophysiology of AD. Autoantibodies against a variety- of molecules have been associated with AD. The roles of these autoantibodies in AD, however, are not well -understood.This review attempts to summarize recent findings on these autoantibodies and explore their potential as diagnostic/ prognostic biomarkers for AD, their roles in the pathogenesis of AD, and their implications in the development of effective immunotherapies for AD.

Jianming Wu, Ling Li. Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications[J]. The Journal of Biomedical Research, 2016, 30(5): 361-372. doi: 10.7555/JBR.30.20150131
Citation: Jianming Wu, Ling Li. Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications[J]. The Journal of Biomedical Research, 2016, 30(5): 361-372. doi: 10.7555/JBR.30.20150131

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return